Found: 16 articles

Article Edition
Pavlova M.G.
Vildagliptin – 15 years in active service with diabetologists
№2 / 2024
M.G. Pavlova
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
№11-12 / 2022
V.I.Simanenkov, S.V. Tikhonov
GASTROENTEROLOGICAL ASPECTS OF BARIATRIC SURGERY
№s5-16 / 2016
D.V. Kurkin, E.V. Volotova, D.A. Bakulin, E.M. Lomkina, I.N. Tyurenkov
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
№5 / 2016
A.M. Mkrtumyan
ALOGLIPTIN – EFFECTIVE AND SAFE DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN THE THERAPY OF TYPE 2 DIABETES MELLITUS
№5 / 2015
I.Yu.Demidova
The Clinical Advantages Of The First Human Glp-1 Analogue Liraglutide In The Treatment Of Patients With Type 2 Diabetes Mellitus
№5 / 2013
M. B. Antsiferov, G. Schernthaner, A.S.Ametov
Innovative Hypoglycemic Therapy: A New Strategy For An Old Problem
№5 / 2013
L.A.Ruyatkina 1, M.Yu.Sorokin 2
Choice Of Gliptins In Different Clinical Situations – Comments To Patient Portraitscentral Tibetian Medical Paintings.
№20 / 2012
G.R. Galstyan
Multivariable Management Of Type 2 Diabetes Mellitus: What Are Our Current Potentials
№16 / 2012
A.M. Shilov, A.G. Abdullayeva
Features Of Treatment Of Glucose Intolerance In Patients With Abdominal-visceral Obesity At Early Stages Of Its Development
№11 / 2012
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
№3 / 2012
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
№16 / 2011


Бионика Медиа